Last reviewed · How we verify
NCT05284838: FAIL CT
Facilitating Adaptive Expertise in Learning Computed Tomography
NA trial testing Error Management Training (Difficult) in Adaptive Expertise in 150 participants. Completed in 30 September 2023.
31 July 2023
Quick facts
| Lead sponsor | Stanford University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | treatment |
| Enrollment | 150 |
| Start date | 18 July 2022 |
| Primary completion | 31 July 2023 |
| Estimated completion | 30 September 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Error Management Training (Difficult)
- Error Management Training (Easy)
- Error Avoidance Training
Conditions studied
- Adaptive Expertise — all drugs for Adaptive Expertise →
- Error Management Training — all drugs for Error Management Training →
- Learning — all drugs for Learning →
Sponsor
Stanford University
Who can join
18 and older, any sex, with Adaptive Expertise or Error Management Training. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The main objective of this study is to demonstrate that Error Management Training improves adaptive expertise in head computed tomography interpretation. The investigators will conduct a randomized controlled trial comparing two learning strategies, Error Management Training vs Error Avoidance Training, in emergency medicine residents. The investigators hypothesize that Error Management Training, as compared to Error Avoidance Training, will improve adaptive expertise, as measured by skills transfer, when used to teach head computed tomography interpretation to emergency medicine residents.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Error Management Training and Adaptive Expertise in Learning Computed Tomography Interpretation: A Randomized Clinical Trial.
Aliaga L, Bavolek RA, Cooper B, Mariorenzi A, et al · · 2024 · cited 3× · PMID 39250155 · DOI 10.1001/jamanetworkopen.2024.31600
Verify or expand the search:
- PubMed search for NCT05284838
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Stanford University trials
Trials by the same sponsor.
- NCT05945147 — Ketamine and Midazolam Infusions for CRPS: Feasibility Study · Phase 2 · withdrawn
- NCT04225949 — Patients Understanding of PROM Graphs · NA · withdrawn
- NCT06273098 — School-Based Bladder Health Intervention · NA · withdrawn
- NCT04652635 — Management of Nailbed Injuries · NA · withdrawn
- NCT05443503 — Stanford Spine Keeper - Managing Your Low Back Pain · NA · suspended
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05284838 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Stanford University
- Last refreshed: 2 April 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05284838.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing